CIRMAP - Centre d'Innovation et de Recherche en Matériaux Polymères
Disciplines :
Chemistry
Author, co-author :
Manini, Giuseppe
Deldime, Maud; ULB - Université Libre de Bruxelles [BE] > Laboratory of Pharmaceutics and Biopharmaceutics > Laboratory of Pharmaceutics and Biopharmaceutics
Benali, Samira ; Université de Mons - UMONS > Faculté des Sciences > Service des Matériaux Polymères et Composites
Raquez, Jean-Marie ; Université de Mons - UMONS > Faculté des Sciences > Service des Matériaux Polymères et Composites
Goole, Jonathan; ULB - Université Libre de Bruxelles [BE] > Laboratory of Pharmaceutics and biopharmaceutics
Language :
English
Title :
Long-acting implantable dosage forms containing paliperidone palmitate obtained by 3D printing
Publication date :
08 May 2021
Journal title :
International Journal of Pharmaceutics
ISSN :
0378-5173
eISSN :
1873-3476
Publisher :
[Elsevier], Amsterdam, Netherlands
Volume :
603
Pages :
1-10
Peer reviewed :
Peer Reviewed verified by ORBi
Research unit :
S816 - Matériaux Polymères et Composites
Research institute :
R400 - Institut de Recherche en Science et Ingénierie des Matériaux
Aho, J., Natalja, G., Magnus, E., Johan, B., Stefania, B., Jukka, R., Drug-loaded poly(E-caprolactone) for 3D printing of personalized medicine: A difference during polymer melt extrusion flows rheological study. Annu. Trans. Nord Rheol. Soc., 24, 2016.
Aho, J., Bøtker, J.P., Genina, N., Edinger, M., Arnfast, L., Roadmap to 3D-printed oral pharmaceutical dosage forms : feedstock filament properties and characterization for fused deposition modeling. J. Pharm. Sci. 108:1 (2019), 26–35, 10.1016/j.xphs.2018.11.012.
Azad, M.A., Olawuni, D., Kimbell, G., Badruddoza, A.Z., Hossain, S., Sultana, T., Polymers for extrusion-based 3D printing of pharmaceuticals : a holistic materials – process perspective. Pharmaceutics, 2020, 1–34.
Cader, H.K., Rance, G.A., Alexander, M.R., et al. Water-based 3D inkjet printing of an oral pharmaceutical dosage form. Int. J. Pharm. 564:April (2019), 359–368, 10.1016/j.ijpharm.2019.04.026.
Cheng, L., Guo, S., Wu, W., Characterization and in vitro release of praziquantel from poly(ε-caprolactone) implants. Int. J. Pharm. 377:1–2 (2009), 112–119, 10.1016/j.ijpharm.2009.05.007.
Darville, N., Heerden, V., Marjolein Vynckier, A., De Meulder, M., Sterkens, P., Annaert, P., Van Den Mooter, G., Intramuscular administration of paliperidone palmitate extended-release injectable microsuspension induces a subclinical inflammatory reaction modulating the pharmacokinetics in rats. Pharm. Drug Deliv. Pharm. Technol., 2014, 10.1002/jps.24014.
Dissolution Methods Database | FDA. https://www.fda.gov/drugs/drug-approvals-and-databases/dissolution-methods-database. Accessed January 29, 2021.
El Aita, I., Breitkreutz, J., Quodbach, J., On-demand manufacturing of immediate release levetiracetam tablets using pressure-assisted microsyringe printing. Eur. J. Pharm. Biopharm. 134 (2019), 29–36, 10.1016/j.ejpb.2018.11.008.
Elmowafy, M., Alruwaili, N.K., Shalaby, K., et al. Long-acting paliperidone parenteral formulations based on polycaprolactone nanoparticles; the influence of stabilizer and chitosan on in vitro release, protein adsorption, and cytotoxicity. Pharmaceutics, 2020.
Fina, F., Goyanes, A., Gaisford, S., Basit, A.W., Selective laser sintering (SLS) 3D printing of medicines. Int. J. Pharm. 529:1–2 (2017), 285–293, 10.1016/j.ijpharm.2017.06.082.
Fina, F., Goyanes, A., Madla, C.M., et al. 3D printing of drug-loaded gyroid lattices using selective laser sintering. Int. J. Pharm. 547:1–2 (2018), 44–52, 10.1016/j.ijpharm.2018.05.044.
Goyanes, A., Martinez, P.R., Buanz, A., Basit, A.W., Gaisford, S., Effect of geometry on drug release from 3D printed tablets. Int. J. Pharm., 2015;(July):1–8, 10.1016/j.ijpharm.2015.04.069.
Goyanes, A., Allahham, N., Tren, S.J., Stoyanov, E., Gaisford, S., Basit, A.W., Direct powder extrusion 3D printing : Fabrication of drug products using a novel single-step process., 567(May), 2019, 10.1016/j.ijpharm.2019.118471.
Holländer, J., Genina, N., Jukarainen, H., et al. Three-dimensional printed PCL-based implantable prototypes of medical devices for controlled drug delivery. J. Pharm. Sci., 105, 2016, 10.1016/j.xphs.2015.12.012.
Huang, S., Donnell, K.P.O., De, V.SMD., Brien, J.O., Stutzman, J., Iii, R.O.W., Processing thermally labile drugs by hot-melt extrusion: the lesson with gliclazide. Eur. J. Pharm. Biopharm., 2017, 10.1016/j.ejpb.2017.05.014.
Infanger, S., Haemmerli, A., Iliev, S., Baier, A., Stoyanov, E., Quodbach, J., Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder. Int. J. Pharm. 2019:555 (August 2018), 198–206, 10.1016/j.ijpharm.2018.11.048.
Jiao, Z., Luo, B., Xiang, S., Ma, H., Yu, Y., Yang, W., Polymer research 3D printing of HA / PCL composite tissue engineering scaffolds. Adv. Ind. Eng. Polym. Res. 2:4 (2019), 196–202, 10.1016/j.aiepr.2019.09.003.
Jonathan, G., Karim, A., 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems. Int. J. Pharmaceutics, 2015, 10.1016/j.ijpharm.2015.12.071.
Kempin, W., Franz, C., Koster, L., et al. Assessment of different polymers and drug loads for fused deposition modeling of drug loaded implants. Eur. J. Pharm. Biopharm., 2017, 10.1016/j.ejpb.2017.02.014.
Khaled, S.A., Burley, J.C., Alexander, M.R., Yang, J., Roberts, C.J., 3D printing of five-in-one dose combination polypill with de fined immediate and sustained release profiles. J. Control. Release 217 (2015), 308–314, 10.1016/j.jconrel.2015.09.028.
Leng, D., Chen, H., Li, G., et al. Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size. Int. J. Pharm., 380–385, 2014, 10.1016/j.ijpharm.2014.05.052.
Li, C., Cheng, L., Zhang, Y., Guo, S., Wu, W., Effects of implant diameter, drug loading and end-capping on praziquantel release from PCL implants. Int. J. Pharm. 386:1–2 (2010), 23–29, 10.1016/j.ijpharm.2009.10.046.
Loh, Z.H., Samanta, A.K., Sia Heng, P.W., Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian J. Pharm. Sci. 10:4 (2014), 255–274, 10.1016/j.ajps.2014.12.006.
Marsac, P.J., Li, T., Taylor, L.S., Estimation of drug – polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. Pharm. Res. 26:1 (2009), 40–44, 10.1007/s11095-008-9721-1.
Martinez, P.R., Goyanes, A., Basit, A.W., Gaisford, S., Fabrication of drug-loaded hydrogels with stereolithographic 3D printing. Int. J. Pharm. 532:1 (2017), 313–317, 10.1016/j.ijpharm.2017.09.003.
Melocchi, A., Uboldi, M., Maroni, A., et al. 3D printing by fused deposition modeling of single- and multi-compartment hollow systems for oral delivery – A review. Int. J. Pharm., 579(February), 2020, 119155, 10.1016/j.ijpharm.2020.119155.
Navitha, A., Jogala, S., Development of novel risperidone implants using blends of polycaprolactones and in vitro in vivo correlation studies. 5:2 (2014), 84–90, 10.4103/2231-4040.133431.
Nober, C., Manini, G., Carlier, E., et al. Feasibility study into the potential use of fused-deposition modeling to manufacture 3D-printed enteric capsules in compounding pharmacies. Int. J. Pharm., 569, 2019, 10.1016/j.ijpharm.2019.118581.
Park, S.Y., Choi, J.W., Park, J.K., et al. Tissue-engineered artificial oesophagus patch using three-dimensionally printed polycaprolactone with mesenchymal stem cells: A preliminary report. Interact Cardiovasc Thorac Surg. 22:6 (2016), 712–717, 10.1093/icvts/ivw048.
Pietrzak, K., Isreb, A., Alhnan, M.A., A flexible-dose dispenser for immediate and extended release 3D printed tablets. Eur. J. Pharm. Biopharm. 96:August (2015), 380–387, 10.1016/j.ejpb.2015.07.027.
Potrč, T., Baumgartner, S., Roškar, R., et al. Electrospun polycaprolactone nanofibers as a potential oromucosal delivery system for poorly water-soluble drugs. Eur. J. Pharm. Sci. 75 (2015), 101–113, 10.1016/j.ejps.2015.04.004.
Remenar, J.F., Making the leap from daily oral dosing to long-acting injectables: Lessons from the antipsychotics. Mol. Pharm. 11:6 (2014), 1739–1749, 10.1021/mp500070m.
Repanas, A., Glasmacher, B., Dipyridamole embedded in Polycaprolactone fibers prepared by coaxial electrospinning as a novel drug delivery system. J. Drug Deliv. Sci. Technol. 29 (2015), 132–142, 10.1016/j.jddst.2015.07.001.
Rychter, M., Baranowska-Korczyc, A., Milanowski, B., et al. Cilostazol-loaded poly(ε-caprolactone) electrospun drug delivery system for cardiovascular applications. Pharm. Res., 35(2), 2018, 10.1007/s11095-017-2314-0.
Sandler, N., Määttänen, A., Ihalainen, P., et al. Inkjet printing of drug substances and use of porous substrates-towards individualized dosing. J. Pharm. Sci., 100(8), 2011, 10.1002/jps.
Sun, H., Mei, L., Song, C., Cui, X., Wang, P., The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials 27 (2006), 1735–1740, 10.1016/j.biomaterials.2005.09.019.
Trivedi, R.K., Jain, P., Patel, M.C., Chatrabhuji, P.M., Trivedi, D.R., A Rapid. Stability Indicating RP-UPLC Method for Determination of Paliperidone Palmitate in a Depot Injectable Formulation. 3:07 (2013), 87–92, 10.7324/JAPS.2013.3716.
Tsume, Y., Mudie, D.M., Langguth, P., Amidon, G.E., Amidon, G.L., The Biopharmaceutics Classification System: Subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC. Eur. J. Pharm. Sci. 23:1 (2014), 1–7, 10.1016/j.ejps.2014.01.009.The.
Wang, B., Zheng, H., Chang, M.W., Ahmad, Z., Li, J.S., Hollow polycaprolactone composite fibers for controlled magnetic responsive antifungal drug release. Colloids Surf. B Biointerfaces 145 (2016), 757–767, 10.1016/j.colsurfb.2016.05.092.
Xu, X., Robles-Martinez, P., Madla, C.M., et al. Stereolithography (SLA) 3D printing of an antihypertensive polyprintlet: Case study of an unexpected photopolymer-drug reaction. Addit. Manuf., 2020(33), December 2019, 101071, 10.1016/j.addma.2020.101071.
Yang, G.H., Lee, H., Kim, G.H., Preparation and characterization of spiral-like micro-struts with nano-roughened surface for enhancing the proliferation and differentiation of preosteoblasts. J. Ind. Eng. Chem. 61 (2018), 244–254, 10.1016/j.jiec.2017.12.022.
Yerragunta, B., Jogala, S., Chinnala, K.M., Aukunuru, J., Development of a novel 3-month drug releasing risperidone microspheres. J. Pharm. Bioallied Sci. 7:1 (2015), 37–44, 10.4103/0975-7406.148777.
